Master of Science in Experimental Medicine (MSc)
Experimental Medicine is the study of the pathogenesis and treatment of disease. Modern experimental medicine represents a rapidly growing body of knowledge involving the determination of diseases processes and the development of appropriate therapies.
The Experimental Medicine Program is intended for individuals seeking a career in research. The Department of Medicine offers opportunities and facilities for advanced studies in experimental medicine, leading toward the M.Sc. and Ph.D. degrees. Members of the Department direct research programs in a wide range of basic and clinically relevant areas. There are a variety of special interest areas of national and international stature. Specialties within the Experimental Medicine Program include: Cardiology, Endocrinology, Gastroenterology, Hematology, Infectious Diseases, Medical Immunology, Medical Oncology, Molecular Biology, Nephrology, Neurology and Respiratory Medicine.
Students may work with investigators located on the main campus of the University of B.C., or they may work in laboratories located off campus (Vancouver General Hospital, Jack Bell Research Centre, Terry Fox Laboratory, St. Paul's Hospital, Biomedical Research Centre, BC Children's Hospital).
It is not required to secure a supervisor at the time of the application, but the application will only be reviewed once a supervisor is secured.
TOEFL (ibT) Overall Score Requirement
IELTS Overall Score Requirement
Prior degree requirements
Applicants with a Bachelor in Science will be considered for entry to this program.
Students who start in the M.Sc. program and who do not have a major scholarship, will receive a minimum stipend of $18,000 per year from their supervisor.
Tuition / Program Costs
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,600.60||$2,811.98|
|Tuition per year||$4,801.80||$8,435.94|
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$923.38 (approx.)|
|Costs of living (yearly)||starting at $16,884.10 (check cost calculator)|
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
Completion Rates & Times
This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.
De Vera, Mary (examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions.)
Devlin, Angela (obesity, children, cardiovascular disease, diabetes, developmental programming)
Dodek, Peter (Determinants of family satisfaction, patient safety, and organizational culture in critical care)
Dong, Xuesen (understand how steroid receptors regulate gene expression and apply this knowledge to treating patients with prostate cancer and premature labour)
Dorscheid, Delbert Richard (Asthma, Inflammatory Respiratory Diseases, Respiratory System)
Doudet, Doris (Brain imaging, mood disorders, stimulation therapies, Parkinson's disease)
Du, Caigan (Kidney transplantation, imnmune disorders, organ preservation, kidney failure, urinary cancer)
Duronio, Vincent (Signal transduction, enzymes, cell regulation, programmed cell death, apoptosis, protein kinase, phosphorylation networks, oxidized LDL, macrophages, gene regulation)
Dutz, Jan Peter (Immunity in Health & Disease, diabetes, dermatology)
Eaves, Constance Jean (Normal and leukemic stem cells, normal and malignant breast stem cells)
Elango, Rajavel (Protein Nutrition, Maternal-Fetal Nutrition, Childhood Malnutrition, Amino Acid Metabolism, Human Nutrition )
Eng, Janice (Neurorehabilitation, spinal cord, brain)
Esdaile, John (Rheumatoid arthritis, osteoarthritis and systemic lupus)
Etminan, Mahyar (Pharmacoepidemiology, Epidemiology, Case-Control Studies, Cohort Studies, Large Health Claims Databases )
Fitzgerald, Mark (asthma; tuberculosis:outcomes evaluation;clinical trials, Epidemiology)
Fleetham, John (Sleep disorders, neuromuscular disorders, obstructive sleep apnea, imaging techniques, respiratory muscle function, systemic blood pressure, hypothalamic pituitary function, psychological status, disordered breathing)
Ford, Nancy (micro-computed tomography, physiological gating, models of respiratory disease, image-based measurements, dental imaging, x-ray imaging)
Gantt, Soren (cytomegalovirus, Burkitt’s lymphoma, Cytomegalovirus, epstein-barr virus, herpes simplex virus, congenital infection, newborn infection, Burkitt)
Garnis, Catherine (Cancer biology; Tumor progression; Oral premalignant lesions; Head and neck cancer; RNA biology, microRNAs; Alternative splicing; Biomarkers)
Ghahary, Aziz (Cell transplantation, diabetes, scaffold, skin substitute, wound healing)
Gonzalez-Montaner, Julio Sergio (Centre for Excellence in HIV/AIDS, development of antiretroviral therapies and management strategies)
Gregory-Evans, Cheryl (Tissue fusion during development, Aniridia, retinal therapeutics)
Gregory-Evans, Kevin (retina, stem cells, gene therapy, retinitis pigmentosa, macular degeneration, age-related macular degeneration, Stargardt’s disease, Best’s disease, x-linked retinoschisis, electroretinography., Eye, novel molcular approaches in the treatment of retinal disease, cell-based therapeutics ofr age-related macular degenration and retinitis pigmentosa, molecular defects underlying retinal disease)
Guns, Emma (Prostate cancer, natural health products, dietary supploements, integrative oncology)